flow trial semaglutide kidney outcomes nejm 2024 hazard ratio Patients with type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. ⁣ ⁣ Whether treatment with would mitigate these risks is unknown. ⁣ ⁣ Semaglutide in patients with overweight

Description

2019;21(2):18l02343

Whether youre exploring your first semaglutide prescription or thinking about switching formats, were here to help you make the choice thats right for you

I have patients with uncontrolled diabetes who need this more than you right now. As for now, its hard to predict how long shortages will remain, with doctors saying it may take a while until the issue is resolved

Some patients get excellent results with natural protocols or benefit from combining medication with bioidentical hormone therapy to address perimenopausal weight gain

Beyond these, in the pre-clinical space, over 25 candidates have been disclosed, but our analysis of patents, company disclosures, and early-stage publications identifies nearly 70 additional undeclared pre-clinical programs